Skip to content

Clinical trials

Observational Sudden Infant Death trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sudden Infant Death Phase: Observational Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20093
20122
20141
20171
20181
20191
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
REGENXBIO Inc.3
Shire2
University of Minnesota2
Denali Therapeutics Inc.1
Duke University1
Medical College of Wisconsin1
Paul Szabolcs1
Rachel Moon, MD1
University of Chicago1
University of Pittsburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sudden Infant Death14
Mucopolysaccharidosis II9
Mucopolysaccharidoses4
Mucopolysaccharidosis I4
Mucopolysaccharidosis VI4
Leukodystrophy, Globoid Cell3
Lysosomal Storage Diseases3
Mucopolysaccharidosis III3
Gaucher Disease2
Mucopolysaccharidosis IV2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.